This selection initiative was jointly guided and organized by the United Front Work Department of the CPC Guangzhou Municipal Committee, the Guangzhou Federation of Industry and Commerce, the Guangzhou Municipal Bureau of Industry and Information Technology, the Guangzhou Municipal State-owned Assets Supervision and Administration Commission, and the Guangzhou Municipal Science and Technology Bureau. Through evaluation, expert research and inspection, and comprehensive assessment across five major industrial sectors—next-generation information technology, semiconductors and integrated circuits, intelligent manufacturing, biomedicine and health, and new energy and new materials—100 innovative enterprises were selected.

In the future, DiQi Pharmaceuticals Co., Ltd will continue to deepen its expertise in developing long-acting innovative formulation technologies, accelerate the advancement of its product pipeline, and develop and manufacture high-quality, highly effective, long-acting, and highly compliant medicines that are affordable for the general public, aiming to become an industry leader.